262 related articles for article (PubMed ID: 24443913)
1. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
Jung GW; Dover DC; Salopek TG
Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
[TBL] [Abstract][Full Text] [Related]
2. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
4. Association between multiple cutaneous melanoma and other primary neoplasms.
Manganoni AM; Pavoni L; Farisoglio C; Sereni E; Chiudinelli M; Calzavara-Pinton P
Clin Exp Dermatol; 2012 Dec; 37(8):857-61. PubMed ID: 23020153
[TBL] [Abstract][Full Text] [Related]
5. Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria.
Troyanova P; Danon S; Ivanova T
Neoplasma; 2002; 49(2):81-5. PubMed ID: 12088110
[TBL] [Abstract][Full Text] [Related]
6. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
[TBL] [Abstract][Full Text] [Related]
7. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
8. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
[TBL] [Abstract][Full Text] [Related]
9. Associations of non-melanoma skin cancer and melanoma, extra-cutaneous cancers and smoking in adults: a US population-based study.
Silverberg JI; Ratner D
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1389-97. PubMed ID: 25491569
[TBL] [Abstract][Full Text] [Related]
10. Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: a national record-linkage study.
Ong EL; Goldacre R; Hoang U; Sinclair R; Goldacre M
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):490-8. PubMed ID: 24609853
[TBL] [Abstract][Full Text] [Related]
11. Incidence of invasive cancers following cutaneous malignant melanoma.
Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
[TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
[TBL] [Abstract][Full Text] [Related]
13. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
14. Elevated risk of second primary cancer in patients with cutaneous malignant melanoma: a nationwide cohort study in Taiwan.
Hwang CY; Chen YJ; Lin MW; Chen TJ; Chu SY; Chen CC; Lee DD; Chang YT; Wan WJ; Liu HN
J Dermatol Sci; 2010 Dec; 60(3):167-72. PubMed ID: 21036546
[TBL] [Abstract][Full Text] [Related]
15. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
[TBL] [Abstract][Full Text] [Related]
16. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
Schenk M; Severson RK; Pawlish KS
Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
[TBL] [Abstract][Full Text] [Related]
17. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological comparisons of index and second primary melanomas in paediatric and adult populations.
Jung GW; Weinstock MA
Br J Dermatol; 2012 Oct; 167(4):882-7. PubMed ID: 22716099
[TBL] [Abstract][Full Text] [Related]
19. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
